相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
Linus Plym Forshell et al.
Oncotarget (2015)
CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
Victoria E. Anderson et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cdk2: a key regulator of the senescence control function of Myc
Per Hydbring et al.
AGING-US (2010)
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity
Elisabet Ognedal Berge et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state
Juergen den Hollander et al.
BLOOD (2010)
Chemoprevention of B-Cell Lymphomas by Inhibition of the Myc Target Spermidine Synthase
TachaZi Plym Forshell et al.
CANCER PREVENTION RESEARCH (2010)
Centrosomal Chk2 in DNA damage responses and cell cycle progession
Amnon Golan et al.
CELL CYCLE (2010)
The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells
Ailine Stolz et al.
NATURE CELL BIOLOGY (2010)
BRCA1 and its toolbox for the maintenance of genome integrity
Michael S. Y. Huen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging
Matthias Altmeyer et al.
AGING-US (2009)
Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine
Andreas Hoglund et al.
BLOOD (2009)
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
Leslie A. Parsels et al.
MOLECULAR CANCER THERAPEUTICS (2009)
DNA damage detection and repair pathways - Recent advances with inhibitors of checkpoint kinases in cancer therapy
Susan Ashwell et al.
CLINICAL CANCER RESEARCH (2008)
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Sonya D. Zabludoff et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template
R. Scott Williams et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
Non-transcriptional control of DNA replication by c-Myc
David Dominguez-Sola et al.
NATURE (2007)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2
Luigi Carlessi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers
Louise H. Williams et al.
CLINICAL CANCER RESEARCH (2006)
The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly
Vladimir Joukov et al.
CELL (2006)
Poly(ADP-ribose):: novel functions for an old molecule
Valerie Schreiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant
EL Kwak et al.
CANCER RESEARCH (2006)
Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining
J Zhuang et al.
CANCER RESEARCH (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
CS Sorensen et al.
NATURE CELL BIOLOGY (2005)
Alternative splicing and mutation status of CHEK2 in stage III breast cancer
V Staalesen et al.
ONCOGENE (2004)
Genetic alterations in hereditary breast cancer
G Cipollini et al.
ANNALS OF ONCOLOGY (2004)
CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer
Peilin Zhang et al.
MOLECULAR CANCER (2004)
Myc pathways provoking cell suicide and cancer
JA Nilsson et al.
ONCOGENE (2003)
Chk1 and Chk2 kinases in checkpoint control and cancer
J Bartek et al.
CANCER CELL (2003)
ATM and related protein kinases: Safeguarding genome integrity
Y Shiloh
NATURE REVIEWS CANCER (2003)
Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription
H Takai et al.
EMBO JOURNAL (2002)
Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain
JY Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells
Q Yu et al.
FEBS LETTERS (2001)
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
J Falck et al.
NATURE (2001)
Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems
M Liu et al.
GENES & DEVELOPMENT (2000)
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
S Matsuoka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
DNA damage-induced activation of p53 by the checkpoint kinase Chk2
A Hirao et al.
SCIENCE (2000)
分享论文
